3QA

(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-(2-{[2-(2-hydroxyethoxy)ethyl]sulfanyl}ethyl)pyrrolidin-3-ol

Created:	2014-10-06
Last modified:	2021-03-01

Find Related PDB Entry
1 entries where 3QA is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	53
Chiral Atom Count	2
Bond Count	55
Aromatic Bond Count	10

2D diagram of 3QA

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-(2-{[2-(2-hydroxyethoxy)ethyl]sulfanyl}ethyl)pyrrolidin-3-ol
Synonyms	2-(2-hydroxyethoxy)ethylthiomethyl-DADMe-Immucillin-A
Systematic Name (OpenEye OEToolkits)	(3R,4S)-1-[(4-azanyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[2-[2-(2-hydroxyethyloxy)ethylsulfanyl]ethyl]pyrrolidin-3-ol
Formula	C₁₇ H₂₇ N₅ O₃ S
Molecular Weight	381.493
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	OCCOCCSCCC3CN(Cc2cnc1c2ncnc1N)CC3O
SMILES	CACTVS	3.385	Nc1ncnc2c(CN3C[CH](O)[CH](CCSCCOCCO)C3)c[nH]c12
SMILES	OpenEye OEToolkits	1.9.2	c1c(c2c([nH]1)c(ncn2)N)CN3CC(C(C3)O)CCSCCOCCO
Canonical SMILES	CACTVS	3.385	Nc1ncnc2c(CN3C[C@H](O)[C@@H](CCSCCOCCO)C3)c[nH]c12
Canonical SMILES	OpenEye OEToolkits	1.9.2	c1c(c2c([nH]1)c(ncn2)N)CN3C[C@@H]([C@H](C3)O)CCSCCOCCO
InChI	InChI	1.03	InChI=1S/C17H27N5O3S/c18-17-16-15(20-11-21-17)13(7-19-16)9-22-8-12(14(24)10-22)1-5-26-6-4-25-3-2-23/h7,11-12,14,19,23-24H,1-6,8-10H2,(H2,18,20,21)/t12-,14-/m0/s1
InChIKey	InChI	1.03	NLPFBCRTOQVKFZ-JSGCOSHPSA-N

Related Resource References

Resource Name	Reference
PubChem	90059759

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.